Follow Us: Follow Prostate on Facebook Follow ProstateNet on Twitter Get the Prostate.net RSS feed

Tag Archives: Risk factors

Finasteride, DHT and Prostate Cancer

Finasteride (Proscar) is a 5-alpha-reductase inhibitor used to treat benign prostatic hypertrophy (BPH) as well as male pattern baldness. When scientists noticed that finasteride inhibited the conversion of testosterone to DHT (a hormone that fuels prostate tumor growth), they initiated a study called the Prostate Cancer Prevention Trial (PCPT) in the early 1990s. (Thompson 2003)… Continue Reading »


More about: , , , , , , , ,

Chondroitin and Prostate Cancer

Chondroitin is a major constituent of cartilage, which provides structure, holds onto water and nutrients, and otherwise helps keep the cartilage healthy. In people who have osteoarthritis, the body loses chondroitin as the cartilage erodes, thus some individuals take chondroitin sulfate supplements to relieve symptoms of the disease and possibly slow its progression. A few… Continue Reading »


More about: , , ,

Prostate Cancer Tumor Size Linked to Body Weight

In men who have prostate cancer, the size of their tumor has a direct correlation to their body weight, according to a study conducted by researchers at Henry Ford Hospital. After evaluating 3,327 men who had had their prostate glands removed via robotic prostatectomy, the investigators reported that men who have the highest body mass… Continue Reading »


More about: , , ,

Cancer Causing Food Additives to Avoid

While the FDA may think some of these additives are safe, known carcinogens are still being allowed to be used in the manufacture of foods and drinks. These are additives you should subtract from your diet immediately. Acesulfame-K: This artificial sweetener is about 200 times sweeter than sugar. Since 1998, the FDA has allowed this… Continue Reading »


More about: , , ,

The Prostate Test: A Laughing Matter Until It’s No Laughing Matter

You’ve probably heard jokes or perhaps even told a few about getting a prostate test or going for a prostate cancer screening. But considering that one in six men in the United States will be diagnosed with prostate cancer, getting a prostate test is no laughing matter. Let’s face it: people poke fun at the… Continue Reading »


More about: , , , , ,

Prostate Cancer Hormone Treatments May Raise Risk of Colorectal Cancer

A large, retrospective population study suggests that prostate cancer treatments that lower male sex hormones may increase the risk of colorectal cancer. Men treated with gonadotropin-releasing hormone (GnRH) agonists or surgical removal of their testicles (orchiectomy) to lower their testosterone and PSA levels experienced an increased risk of colorectal cancer of about 20 to 40… Continue Reading »


More about: , ,

Prostate Cancer Patients Treated With Robotic-Assisted Surgery Can Expect Low Recurrence of Cancer

ScienceDaily (Oct. 20, 2010)  A first-ever, long-term study of patients who underwent robot-assisted surgery to remove their cancerous prostates found that nearly 87 percent of them had no recurrence of the disease after five years. The findings were reported in this month’s issue of the European Urology journal by a team of Henry Ford Hospital… Continue Reading »


More about: , , ,

Physicians Committee for Responsible Medicine (PCRM) Promotion of Healthy Living through Vegetarianism

More about: , ,

Non-Dairy Calcium May Increase Prostate Cancer Risk

A first-of-its-kind study has found evidence that dietary calcium, including calcium from non-dairy sources, may increase the risk of prostate cancer. Results of the study, which involved Chinese men, were published in Cancer Research. Previous studies performed in populations in North America and Europe have noted an association between a high consumption of dairy foods… Continue Reading »


More about: , , ,

Prostate Cancer Risk Rises with Heavy Alcohol Use

Men who are heavy alcohol users are at least twice as likely to be diagnosed with high-grade prostate cancer than those who engage in less heavy drinking. That’s the word from researchers at the University of California San Francisco. In the University of California study, which was published in the journal Cancer, researchers evaluated data… Continue Reading »


More about: , , ,

  • ADVERTISEMENT


  • ADVERTISEMENT